Improving Patient Access to Stroke Therapy Study
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2017
Price : $35 *
At a glance
- Drugs Alteplase (Primary)
- Indications Embolism and thrombosis; Stroke; Transient ischaemic attacks
- Focus Therapeutic Use
- Acronyms IMPACT
- 01 Mar 2017 Status changed from suspended to discontinued.
- 06 Nov 2015 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 06 Apr 2015 Planned End Date changed from 1 Jul 2014 to 1 Jun 2017 as reported by ClinicalTrials.gov.